$6.00
0.5910.91%
Last update: Jul 16, 8:06 AM
15 minutes delayed
Comments
Loading...
Journey Medical
DERMNASDAQ
Journey Medical (NASDAQ:DERM) Stock, Analyst Ratings, Price Targets, Forecasts
Journey Medical Corp has a consensus price target of $10.58 based on the ratings of 6 analysts. The high is $15 issued by Roth Capital on December 16, 2021. The low is $6 issued by B. Riley Securities on September 7, 2023. The 3 most-recent analyst ratings were released by Roth MKM, Alliance Global Partners, and B. Riley Securities on June 28, 2024, February 16, 2024, and September 7, 2023, respectively. With an average price target of $8.5 between Roth MKM, Alliance Global Partners, and B. Riley Securities, there's an implied 41.67% upside for Journey Medical Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Roth MKM
Alliance Global Partners
B. Riley Securities
Cantor Fitzgerald
Roth Capital
1calculated from analyst ratings
Analyst Ratings for Journey Medical
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/28/2024 | Buy Now | 83.33% | Roth MKM | Jason Wittes | → $11 | Reinstates | → Buy | Get Alert |
| 02/16/2024 | Buy Now | 41.67% | Alliance Global Partners | Scott Henry | → $8.5 | Initiates | → Buy | Get Alert |
| 09/07/2023 | Buy Now | — | B. Riley Securities | Kalpit Patel | → $6 | Reiterates | Buy → Buy | Get Alert |
| 07/12/2023 | Buy Now | — | B. Riley Securities | Kalpit Patel | $3 → $6 | Maintains | Buy | Get Alert |
| 05/23/2023 | Buy Now | -50% | B. Riley Securities | Kalpit Patel | $6 → $3 | Maintains | Buy | Get Alert |
| 03/30/2023 | Buy Now | — | B. Riley Securities | Kalpit Patel | → $6 | Reiterates | → Buy | Get Alert |
| 02/25/2022 | Buy Now | 50% | Cantor Fitzgerald | Brandon Folkes | → $9 | Initiates | → Overweight | Get Alert |
| 12/16/2021 | Buy Now | 150% | Roth Capital | Scott Henry | — | Initiates | → Buy | Get Alert |
| 12/07/2021 | Buy Now | 133.33% | B. Riley Securities | — | — | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Journey Medical (DERM) stock?
The latest price target for Journey Medical (NASDAQ:DERM) was reported by Roth MKM on June 28, 2024. The analyst firm set a price target for $11.00 expecting DERM to rise to within 12 months (a possible 83.33% upside). 3 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Journey Medical (DERM)?
The latest analyst rating for Journey Medical (NASDAQ:DERM) was provided by Roth MKM, and Journey Medical their buy rating.
When was the last upgrade for Journey Medical (DERM)?
There is no last upgrade for Journey Medical
When was the last downgrade for Journey Medical (DERM)?
There is no last downgrade for Journey Medical.
When is the next analyst rating going to be posted or updated for Journey Medical (DERM)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Journey Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Journey Medical was filed on June 28, 2024 so you should expect the next rating to be made available sometime around June 28, 2025.
Is the Analyst Rating Journey Medical (DERM) correct?
While ratings are subjective and will change, the latest Journey Medical (DERM) rating was a with a price target of $0.00 to $11.00. The current price Journey Medical (DERM) is trading at is $6.00, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.